Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
RCKT —
ROCKET PHARMACEUTICALS INC
CUSIP: 77313F106 · Held by 3 superinvestors · Combined value: $14,962,691
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Lee Ainslie | 0.1% | $8,821,016 | 2,513,110 | REDUCE | -5,955,234 |
| 2 | Ken Griffin | 0.0% | $4,663,354 | 1,328,591 | REDUCE | -516,236 |
| 3 | Jim Simons | 0.0% | $1,478,321 | 421,174 | ADD | +283,997 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +283,997 | +207.0% |
| Ken Griffin | REDUCE | -516,236 | -28.0% |
| Lee Ainslie | REDUCE | -5,955,234 | -70.3% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +1,525,477 | +477.7% |
| Lee Ainslie | ADD | +104,531 | +1.2% |
| Jim Simons | REDUCE | -324,197 | -70.3% |
Who Owns RCKT? Superinvestor Holdings
ROCKET PHARMACEUTICALS INC is held by 3 tracked superinvestors, with a combined position value of $15 million . The largest positions are held by Lee Ainslie (0.1% of portfolio), Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 2 reduced or exited.